International Peer Reviewed Scientific Journal Publishes BioCurex Inc. Article Showing That a Combination of its Cancer Marker RECAF and CA125 Can be Used for Ovarian Cancer Screening

RICHMOND, British Columbia, June 8, 2011 (GLOBE NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) today announced the publication of the article entitled: "Combination of CA125 and RECAF biomarkers for early detection of ovarian cancer" in a peer reviewed scientific journal specialized in cancer markers.